Patents Assigned to LPL Technologies, Inc.
  • Patent number: 6716595
    Abstract: The present invention relates to non-radioactive enzymatic methods for detecting Sphingosine-1-Phosphate (S1P) in biological fluids. The present invention further relates to a method of detecting the presence of cancer in a patient by the use of these and other methods of detecting S1P in biological samples from a patient.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: April 6, 2004
    Assignee: LPL Technologies, Inc.
    Inventors: Michael K. Skinner, Jodi L. Johnson, Jeff A. Parrott